Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vertex Pharma books larger 3rd-quarter loss as collaboration revenue falls, costs increase
Yahoo/AP
Monday, October 26, 2009 - 6:04pm
tags:
Vertex Pharmaceuticals, earnings
Earnings Preview: GlaxoSmithKline Q3 earns seen up
Yahoo/AP
Monday, October 26, 2009 - 6:02pm
tags:
GSK, earnings
Abbott Laboratories: Dividend Stock Analysis
Seeking Alpha
Monday, October 26, 2009 - 12:02pm
tags:
Abbott Laboratories, dividends
Pfizer Produces Snapshot of Combined Company: $66B in Revenue; Only $2.2B in Cash
BNET Pharma
Monday, October 26, 2009 - 11:59am
tags:
Pfizer, Wyeth, M&A, earnings
Effient and Onglyza Start Slow—And That May Not Be A Bad Thing
InVivo
Monday, October 26, 2009 - 11:57am
tags:
Effient, Onglyza, diabetes, Eli Lilly, Bristol-Myers Squibb, Daiichi Sankyo, Prasugrel
FDA doesn't act on post-marketing data
Fierce Pharma
Monday, October 26, 2009 - 11:56am
tags:
post-marketing data, FDA
Shire gets boost as FDA backs Vyvanse exclusivity
Reuters
Monday, October 26, 2009 - 11:55am
tags:
Shire, FDA, Vyvanase, ADHD
[video] Vivus CEO on Diet Drug
CNBC
Monday, October 26, 2009 - 11:38am
tags:
Vivus, obesity, Qnexa, Pharma CEOs, Leland WIlson
Antigenics buoyed by brain-cancer study
Bizjournals.com
Monday, October 26, 2009 - 11:36am
tags:
brain cancer, Antigenics
Cephalon close to buying BioAssets, developer of sciatica treatment
Bizjournals.com
Monday, October 26, 2009 - 11:32am
tags:
sciatica, Cephalon, M&A, BioAssets
SuperGen, GlaxoSmithKline sign collaboration deal
Marketwatch
Monday, October 26, 2009 - 9:43am
tags:
GSK, Supergen, partnerships, drug development
For AstraZeneca, Making Drugs Is Like Making Cars
Pharmalot
Monday, October 26, 2009 - 9:41am
tags:
AstraZeneca
Brain Disease Found in 3rd Patient on Roche’s Rituxan
Bloomberg
Monday, October 26, 2009 - 9:40am
tags:
Roche, Genentech, arthritis, Rituxan
Ranbaxy Posts Profit on Lower Costs, Currencies
Bloomberg
Monday, October 26, 2009 - 9:30am
tags:
Ranbaxy, India, earnings
Swine Flu Doesn't Need to Save Novartis
Motley Fool
Monday, October 26, 2009 - 9:29am
tags:
Novartis, swine flu, H1N1, vaccines
FDA Approves Use of Experimental Antiviral For H1N1 Flu
WSJ Online
Monday, October 26, 2009 - 9:26am
tags:
antivirals, Biocryst, swine flu, H1N1, FDA
J&J wants deals with rivals to share risk
FT.com
Monday, October 26, 2009 - 9:24am
tags:
JNJ, M&A
Venture Capital Flows to Biotech as Public Financing Takes a Breather
Seeking Alpha
Sunday, October 25, 2009 - 12:40pm
tags:
biotech
Divi’s Laboratories: Buy
istockanalyst.com
Sunday, October 25, 2009 - 12:34pm
tags:
Divi's Laboratories
AEterna Zentaris Receives US$5.5 Million from Institutional Investors
Yahoo/PR NewsWire
Saturday, October 24, 2009 - 11:15am
tags:
Aeterna Zentaris

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.